- Home
- BTMD vs ATRA Comparison
BTMD vs ATRA Comparison
Compare BTMD & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- ATRA
- Stock Information
- Founded
- BTMD 2012
- ATRA 2012
- Country
- BTMD United States
- ATRA United States
- Employees
- BTMD N/A
- ATRA N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTMD Health Care
- ATRA Health Care
- Exchange
- BTMD Nasdaq
- ATRA Nasdaq
- Market Cap
- BTMD 90.6M
- ATRA 97.0M
- IPO Year
- BTMD N/A
- ATRA 2014
- Fundamental
- Price
- BTMD $2.65
- ATRA $12.89
- Analyst Decision
- BTMD Buy
- ATRA Strong Buy
- Analyst Count
- BTMD 2
- ATRA 3
- Target Price
- BTMD $6.00
- ATRA $21.00
- AVG Volume (30 Days)
- BTMD 117.0K
- ATRA 57.6K
- Earning Date
- BTMD 11-05-2025
- ATRA 11-06-2025
- Dividend Yield
- BTMD N/A
- ATRA N/A
- EPS Growth
- BTMD 270.48
- ATRA N/A
- EPS
- BTMD 0.78
- ATRA 0.56
- Revenue
- BTMD $195,645,000.00
- ATRA $188,667,000.00
- Revenue This Year
- BTMD N/A
- ATRA N/A
- Revenue Next Year
- BTMD $4.85
- ATRA N/A
- P/E Ratio
- BTMD $3.34
- ATRA $22.41
- Revenue Growth
- BTMD 1.34
- ATRA 202.41
- 52 Week Low
- BTMD $2.43
- ATRA $5.01
- 52 Week High
- BTMD $6.98
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- BTMD 41.31
- ATRA 44.47
- Support Level
- BTMD $2.43
- ATRA $10.53
- Resistance Level
- BTMD $2.98
- ATRA $15.30
- Average True Range (ATR)
- BTMD 0.17
- ATRA 1.26
- MACD
- BTMD -0.02
- ATRA -0.31
- Stochastic Oscillator
- BTMD 26.92
- ATRA 40.08
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).